NYSE:WST West Pharmaceutical Services Q3 2025 Earnings Report $270.24 +3.06 (+1.14%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$270.54 +0.30 (+0.11%) As of 10/17/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast West Pharmaceutical Services EPS ResultsActual EPSN/AConsensus EPS $1.67Beat/MissN/AOne Year Ago EPSN/AWest Pharmaceutical Services Revenue ResultsActual RevenueN/AExpected Revenue$788.42 millionBeat/MissN/AYoY Revenue GrowthN/AWest Pharmaceutical Services Announcement DetailsQuarterQ3 2025Date10/23/2025TimeBefore Market OpensConference Call DateThursday, October 23, 2025Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile West Pharmaceutical Services Earnings Headlines1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Turn DownOctober 16 at 8:40 AM | finance.yahoo.comWeiss Ratings Reiterates Hold (C) Rating for West Pharmaceutical Services (NYSE:WST)October 16 at 2:45 AM | americanbankingnews.comCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.October 19 at 2:00 AM | SmartAsset (Ad)West Pharmaceutical Services (WST): Exploring Valuation as Analyst Confidence Grows Ahead of Q3 EarningsOctober 10, 2025 | finance.yahoo.comWest to Host Third-Quarter 2025 Conference CallOctober 9, 2025 | prnewswire.comWEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmOctober 8, 2025 | globenewswire.comSee More West Pharmaceutical Services Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like West Pharmaceutical Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your email. Email Address About West Pharmaceutical ServicesWest Pharmaceutical Services (NYSE:WST) is a global leader in the design and manufacturing of drug packaging and delivery solutions for the pharmaceutical and biotechnology industries. The company specializes in elastomeric and polymer components that ensure the integrity and safety of injectable medicines, including vial stoppers, syringe plungers, cartridge-based delivery systems and complete safety-engineered administration devices. With a product portfolio that spans containment and delivery platforms, West supports both traditional small-molecule injectables and advanced biologics. Its offerings include prefillable syringe systems, custom-engineered polymer components and integrated safety systems designed to reduce needlestick injuries and enhance patient compliance. The company also provides design, testing and regulatory support to help customers accelerate development timelines and meet stringent global quality standards. Founded in 1923 and headquartered in Exton, Pennsylvania, West has grown into a multinational enterprise serving more than 200 customers in over 50 countries. The company operates manufacturing facilities, R&D centers and technical service laboratories across North America, Europe and Asia-Pacific. This global footprint enables close collaboration with leading pharmaceutical and biotech firms at every stage of drug development and commercialization. Under the leadership of President and Chief Executive Officer Eric P. Green, West continues to invest in innovation, quality assurance and sustainability initiatives. The company’s long-standing relationships with top global drug makers, combined with its emphasis on engineering excellence and regulatory compliance, have positioned West as a trusted partner in advancing injectable therapies worldwide.View West Pharmaceutical Services ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Goldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Upcoming Earnings Nasdaq (10/21/2025)Texas Instruments (10/21/2025)Intuitive Surgical (10/21/2025)Netflix (10/21/2025)Verizon Communications (10/21/2025)General Motors (10/21/2025)CocaCola (10/21/2025)Citigroup (10/21/2025)3M (10/21/2025)RTX (10/21/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
